Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	DXCMDexcom	GEHCGE HealthCare	RMDResMed
Snapshot
Price	$89.89	$66.08	$224.92
Market cap	$27.49B	$29.82B	$30.41B
Valuation
P/E	37.6x	16.1x	21.5x
Forward P/E	26.9x	18.4x	18.4x
Growth
Revenue growth	16.1%	6.0%	10.3%
EPS growth	77.5%	-12.3%	16.5%
Profitability
Net margin	19.3%	9.1%	27.4%
ROE	33.8%	18.8%	24.4%
Balance sheet & cash
Debt / equity	0.47x	0.97x	0.11x
Free cash flow yield	1.8%	7.7%	3.8%
Dividend yield	—	0.2%	1.2%
Verdict
Investment rating	Favorable· 70	Neutral· 51	Strong· 75

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	DXCMtoday $90	GEHCtoday $66	RMDtoday $225
2027	$119.63 – $175.46+95% CAGR	$50.55 – $74.14+12% CAGR	$196.47 – $288.16+28% CAGR
2028	$212.29 – $311.36+86% CAGR	$51.56 – $75.62+7% CAGR	$228.83 – $335.62+22% CAGR
2029	$376.70 – $552.50+83% CAGR	$52.59 – $77.14+5% CAGR	$266.52 – $390.90+20% CAGR
2030	$668.46 – $980.41+82% CAGR	$53.65 – $78.68+4% CAGR	$310.42 – $455.28+19% CAGR
2031	$1,186.19 – $1,739.74+81% CAGR	$54.72 – $80.25+4% CAGR	$361.54 – $530.26+19% CAGR
5-yr CAGR	67.5% – 80.9%	-3.7% – 4.0%	10.0% – 18.7%